Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation

Elevance Health Inc. (NYSE:ELV) shares are jumping Thursday after the company reaffirmed its full-year 2026 earnings guidance ahead of a series of investor meetings. Here's what you should know.

Benzinga • Sep 10, 2026

UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?

UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.

Zacks Investment Research • Aug 25, 2026

U.S. Health Insurers Raise Outlooks Despite Q2 Cost Rises, Shifting Membership

Most leading US publicly traded managed care insurers raised their full-year earnings estimates following second quarter results, despite increasing medical costs and membership attrition. Many of the top publicly traded US managed care insurers' medical costs rose in the second quarter of 2026, following notable increases throughout 2025.

Seeking Alpha • Aug 18, 2026

Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?

Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Aug 14, 2026

Diamond Hill Large Cap Fund Q2 2026 Portfolio Update

Key contributors include Texas Instruments, Humana, and Nucor. Key detractors include Zoetis, ConocoPhillips, and Accenture. New positions include Elevance Health, FedEx Freight, and Humana.

Seeking Alpha • Aug 13, 2026

Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey

INDIANAPOLIS--(BUSINESS WIRE)--Cancer care is often overwhelming, not just medically, but emotionally and logistically. Elevance Health is strengthening its connected cancer care model to enhance support consumers receive throughout their care journeys, with a focus on earlier support, personalized care navigation, and more coordinated care.Each year in the U.S., 1.8 million people are diagnosed with cancer. For many patients, a cancer diagnosis brings not only medical decisions, but also a comp.

Business Wire • Jul 30, 2026

Oakmark U.S. Large Value Strategy Q2 2026 Portfolio Review

Delta Air Lines was a contributor during the quarter. Fuel prices spiked in March following the onset of the Iran War, creating a near-term headwind for airline profitability. Intercontinental Exchange stock price declined due to market concerns about AI disruption and potential competition from new exchanges launching perpetual futures. We were pleased to initiate a position in Equitable Holdings at a meaningful discount to intrinsic value.

Seeking Alpha • Jul 29, 2026

GreensKeeper Value Fund Q2 2026 Portfolio Update

Our top performer in the second quarter was ICON plc, which gained 57%. Our largest detractor during the quarter was Intercontinental Exchange, which declined 21.7%. We made no major changes to the portfolio during the quarter.

Seeking Alpha • Jul 27, 2026

Billionaire Investor Seth Klarman's Top 5 Stocks: Would He Buy More Today?

Seth Klarman's Baupost Group rarely shows its cards, so when the latest 13F filing (holdings as of March 31, 2026, filed May 14, 2026) disclosed his five largest long common-stock positions, the disclosure read like a treasure map.

24/7 Wall Street • Jul 25, 2026

Artisan Value Fund Q2 2026 Portfolio Update

US equities advanced during Q2, supported by another quarter of better-than-expected corporate earnings and continued enthusiasm for companies benefiting from artificial intelligence-related investment. Our bottom five contributors to return in Q2 were Accenture, CME Group, Salesforce, Boston Scientific and EOG Resources. Our top five contributors to return in Q2 were Texas Instruments, Lam Research, NXP Semiconductors, Elevance Health and Alphabet.

Seeking Alpha • Jul 21, 2026